News of Note—Bavarian Nordic, vaccine hesitancy and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> The U.S. government signed off on a $44 million option in its smallpox vaccine contract with Bavarian Nordic. Release

> WHO has named vaccine hesitancy and Ebola among its top 10 threats to global health in 2019. ABC News article

> An Alzheimer's disease vaccine from United Neuroscience performed favorably in a phase 2 study, the biotech said. Bloomberg Businessweek article

> Valneva secured a $59 million contract with the U.S. Department of Defense to supply its Japanese encephalitis vaccine Ixiaro. Release

> CDMO Almac is expanding its capacity to manufacture personalized cancer vaccines. Outsourcing-Pharma article

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.